KLRK1
NKG2-D type II integral membrane protein
Also known as: CD314, D12S2489E, KLR, NKG2-D, NKG2D, NKG2D_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26718
- Gene
- KLRK1
- Ensembl
- ENSG00000213809
- Chromosome
- 12
- Canonical length
- 216 aa
- Protein class
- Cancer-related genes, CD markers, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This locus represents naturally occurring read-through transcription between the neighboring KLRC4 (killer cell lectin-like receptor subfamily C, member 4) and KLRK1 (killer cell lectin-like receptor subfamily K, member 1) genes on chromosome 12. The read-through transcript includes an alternate 5' exon and lacks a significant portion of the KLRC4 coding sequence, including the start codon, and it thus encodes the KLRK1 protein. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
216 residues, UniProt reviewed canonical sequence.
>P26718|KLRK1
1 MGWIRGRRSR HSWEMSEFHN YNLDLKKSDF STRWQKQRCP VVKSKCRENA SPFFFCCFIA
61 VAMGIRFIIM VTIWSAVFLN SLFNQEVQIP LTESYCGPCP KNWICYKNNC YQFFDESKNW
121 YESQASCMSQ NASLLKVYSK EDQDLLKLVK SYHWMGLVHI PTNGSWQWED GSILSPNLLT
181 IIEMQKGDCA LYASSFKGYI ENCSTPNTYI CMQRTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLRK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- spleen: 39 nTPM
- lymph node: 35 nTPM
- bone marrow: 21 nTPM
- tonsil: 18 nTPM
- appendix: 12 nTPM
- small intestine: 11 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 25 nCPM
- nk-cells: 23 nCPM
- t-cells: 12 nCPM
- oligodendrocytes: 8.3 nCPM
- b-cells: 1.4 nCPM
- bergmann glia: 0.9 nCPM
Immune cell
- NK-cell: 336 nTPM
- gdT-cell: 287 nTPM
- memory CD8 T-cell: 260 nTPM
- naive CD8 T-cell: 259 nTPM
- total PBMC: 128 nTPM
- MAIT T-cell: 111 nTPM
Brain region
- white matter: 2.1 nTPM
- medulla oblongata: 1.8 nTPM
- cerebral cortex: 1.6 nTPM
- basal ganglia: 1.4 nTPM
- pons: 1.3 nTPM
- spinal cord: 1.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.8
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- cell differentiation
- cellular response to lipopolysaccharide
- defense response to Gram-positive bacterium
- natural killer cell activation
- natural killer cell mediated cytotoxicity
- negative regulation of GTPase activity
- negative regulation of natural killer cell chemotaxis
- nitric oxide biosynthetic process
- positive regulation of natural killer cell mediated cytotoxicity
- positive regulation of nitric oxide biosynthetic process
- positive regulation of type II interferon production
- signal transduction
- stimulatory C-type lectin receptor signaling pathway
- T cell costimulation
Molecular functions
- carbohydrate binding
- identical protein binding
- MHC class I protein binding
- MHC class Ib receptor activity
- signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C-type lectin-like
- C-type lectin-like/link domain superfamily
- C-type lectin fold
- Natural killer cell receptor-like, C-type lectin-like domain
- Lectin C-type domain
- NKG2-D type II integral membrane protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KLRK1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLRK1 as an antibody target. Whether an autoantibody or antibody against KLRK1 could matter depends on whether native KLRK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLRK1 is annotated at the cell surface, where native KLRK1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KLRK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...